RTTNews | Jun 7, 2021 10:05AM EDT

10:04 Monday, June 7, 2021 (RTTNews.com) - Shares of Bionano Genomics, Inc. (BNGO) are currently gaining over 18% as the company named Jason Priar as its chief commercial officer.

BNGO is currently trading at $8.17, up $1.30 or $18.90%, on the Nasdaq. For the 52-week period, the stock has traded between $0.43 and $15.69.

Priar has held sales leadership positions at GeneDx, Sema4 and PerkinElmer Genomics. His experience includes sales in genetic diseases and cancer testing as well as pharmaceutical sales.

"We believe he has the experience in scaling revenues and obtaining market access from third party payers that we need to accelerate global adoption of optical genome mapping (OGM) with our Saphyr system and drive Lineagen's business of providing diagnostic services in pediatric neurodevelopmental disorders," commented Erik Holmlin, PhD, CEO of Bionano Genomics.

Read the original article on RTTNews ( https://www.rttnews.com/3200449/stock-alert-bionano-genomics-jumps-18-after-jason-priar-appointed-chief-commercial-officer.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved